未登录FRONTIER-2: A phase 2b, long-term extension, dose-ranging study of oral JNJ-77242113 for the treatment of moderate-to-severe plaque psoriasis
Ferris, Laura K.; Bagel, Jerry; Huang, Yu-Huei; Pink, Andrew E.; Tyring, Stephen K.; Kokolakis, Georgios; Delozier, Amy M.; Li, Shu; Shen, Yaung-Kaung; Iaconangelo, Charles; Ota, Takayuki; Bissonnette, Robert
分享
收藏
分享
收藏
分享
收藏